Colgate-Palmolive Company

NYSE:CL Stok Raporu

Piyasa değeri: US$70.5b

Colgate-Palmolive Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Colgate-Palmolive kazanç ve gelirin sırasıyla yıllık 12.1% ve 3.2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 13.2% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 255.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

12.1%

Kazanç büyüme oranı

13.16%

EPS büyüme oranı

Household Products kazanç büyümesi4.6%
Gelir büyüme oranı3.2%
Gelecekteki özkaynak getirisi255.29%
Analist kapsamı

Good

Son güncelleme12 May 2026

Gelecekteki son büyüme güncellemeleri

Analiz Makalesi • Aug 04

Colgate-Palmolive Company (NYSE:CL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Shareholders might have noticed that Colgate-Palmolive Company ( NYSE:CL ) filed its quarterly result this time last...

Recent updates

Seeking Alpha • May 10

Colgate-Palmolive: Too Expensive For A Defensive Firm

Summary Colgate-Palmolive delivered 8% sales growth in Q1 2026, but EPS declined 6%, warranting a conservative hold rating. I see organic growth of just 2.9%, with North America sales falling due to increased toothpaste competition and margin compression. FX tailwinds drove significant growth in Latin America, EMEA, and APAC, raising concerns about sustainability if currency trends reverse. Persistent low U.S. consumer confidence and elevated input costs, including a $300M Middle East impact, create near-term headwinds for CL. Read the full article on Seeking Alpha
Anlatı Güncellemesi • Apr 09

CL: 2030 Plan Execution And Margins Will Shape 2026 Setup

Analysts have trimmed the Colgate-Palmolive fair value estimate by about $0.58 to $96.68, reflecting slightly softer revenue growth assumptions, a modestly lower future P/E, and mixed recent research that includes both reduced price targets and an upgrade tied to confidence in the 2030 plan and ongoing margin resilience. Analyst Commentary Recent Street research on Colgate-Palmolive shows a mix of optimism around the long-term plan and caution around nearer term cost and valuation risks.
Anlatı Güncellemesi • Mar 25

CL: 2030 Plan And Emerging Markets Execution Will Shape 2026 Setup

Colgate-Palmolive's fair value estimate edges up to $97.26 from $97.21 as analysts lift price targets toward the $100 to $105 range, citing stronger confidence in the 2030 plan, product innovation, and emerging markets execution. Analyst Commentary Recent Street research on Colgate-Palmolive clusters around higher price targets and upgraded ratings, with the fair value conversation increasingly framed around the 2030 plan, execution in emerging markets, and portfolio moves such as the exit from private label pet food.
Anlatı Güncellemesi • Mar 10

CL: 2030 Plan And Emerging Markets Support Measured 2026 Execution Setup

Analysts have nudged their price expectations for Colgate-Palmolive higher, with the updated fair value estimate moving from about $96.68 to roughly $97.21. They cite growing confidence in the company’s 2030 plan, product innovation efforts and emerging markets exposure, as reflected in a series of recent price target increases across major firms.
Anlatı Güncellemesi • Feb 24

CL: 2030 Plan And Emerging Markets Will Drive Balanced 2026 Setup

Analysts have raised their implied price target for Colgate-Palmolive by about $8 to reflect higher conviction in the company’s 2030 plan, product innovation pipeline and emerging market exposure, as well as refreshed views on sector valuations. Analyst Commentary Recent research has centered on how Colgate-Palmolive’s 2030 plan, product pipeline and emerging market footprint feed into both growth potential and current valuation.
Analiz Makalesi • Feb 06

There May Be Some Bright Spots In Colgate-Palmolive's (NYSE:CL) Earnings

Colgate-Palmolive Company's ( NYSE:CL ) recent soft profit numbers didn't appear to worry shareholders, as the stock...
Anlatı Güncellemesi • Jan 28

CL: Emerging Markets And 2026 Setup Will Shape Balanced Risk Reward

Analysts have nudged their price targets for Colgate-Palmolive higher, reflected in a modest fair value move from about $87.47 to $88.89. They are factoring in slightly stronger revenue growth assumptions, a marginally higher future P/E and recent rating and target changes across firms such as Barclays, JPMorgan, UBS, Wells Fargo, Piper Sandler and TD Cowen.
Anlatı Güncellemesi • Jan 10

CL: Emerging Markets And 2026 Setup Support Balanced Outlook After Recent Softness

Our updated analyst price target for Colgate-Palmolive edges up to about US$87.47 from roughly US$87.21, as analysts balance slightly softer modeled revenue growth with modestly higher profit margin and future P/E assumptions. This view is supported by recent research that pairs cautious consumer staples outlooks with a more positive stance on the company’s emerging markets exposure and potential 2026 acceleration.
Anlatı Güncellemesi • Dec 15

CL: Emerging Market Strength Will Support Gradual Recovery As Q3 Softness Fades

Analysts have trimmed their price target on Colgate-Palmolive to $87 from the low-to-mid $90s, reflecting near term softness in Q3 results and muted personal care growth, even as they expect organic sales momentum to gradually improve. Analyst Commentary Analysts remain divided on Colgate-Palmolive, with recent target cuts reflecting near term execution risk, while longer term growth and margin recovery expectations stay largely intact.
Anlatı Güncellemesi • Nov 30

CL: Gradual Recovery Expected As Temporary Headwinds Ease In Personal Care Markets

Narrative Update on Colgate-Palmolive Colgate-Palmolive's analyst price target has been modestly reduced by $0.05 to $87.21. Analysts cite near-term growth challenges and muted sector outlooks following a soft Q3, but expect gradual improvement as temporary pressures ease.
Anlatı Güncellemesi • Nov 16

CL: Organic Sales Momentum Will Rebound As Near-Term Headwinds Ease

Colgate-Palmolive's analyst consensus price target was revised downward from approximately $88.84 to $87.26. Analysts cite a soft third quarter, moderated growth expectations, and ongoing category headwinds as key factors behind the adjustment.
Anlatı Güncellemesi • Nov 02

CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds

Colgate-Palmolive’s fair value estimate has been reduced from $90.74 to $88.84 per share. Analysts cite persistent category headwinds and a moderated sales outlook as factors behind lower price targets across the sector.
Anlatı Güncellemesi • Oct 18

Emerging Markets And Digital Transformation Will Unlock Global Value

Colgate-Palmolive's analyst fair value price target has decreased from $93.11 to $90.74. Analysts cite lowered sales guidance, persistent category headwinds, and muted growth outlooks as key factors behind their revised estimates.
Anlatı Güncellemesi • Oct 03

Emerging Markets And Digital Transformation Will Unlock Global Value

Colgate-Palmolive's analyst price target has been revised downward by approximately $2 to $93. Analysts cite ongoing category headwinds and decelerating growth in the personal care sector as reasons for this adjustment.
Analiz Makalesi • Sep 30

There's Reason For Concern Over Colgate-Palmolive Company's (NYSE:CL) Price

Colgate-Palmolive Company's ( NYSE:CL ) price-to-earnings (or "P/E") ratio of 22.3x might make it look like a sell...
Analiz Makalesi • Aug 04

Colgate-Palmolive Company (NYSE:CL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Shareholders might have noticed that Colgate-Palmolive Company ( NYSE:CL ) filed its quarterly result this time last...
Analiz Makalesi • Jun 27

Colgate-Palmolive (NYSE:CL) Has A Pretty Healthy Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analiz Makalesi • Jun 12

Do Colgate-Palmolive's (NYSE:CL) Earnings Warrant Your Attention?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Seeking Alpha • Apr 22

A Historic Brand, A Fresh Approach: Inside Colgate-Palmolive's Machine

Summary Colgate-Palmolive achieved over $20 billion in revenue in 2024, driven by strong brand identity, operational discipline, and a diversified product portfolio across Oral Care, Personal Care, Home Care, and Pet Nutrition. The company maintained profitability despite inflation, with a 14.4% margin, and continued to invest in marketing and R&D, enhancing brand differentiation and price stability. Financially robust, Colgate-Palmolive showed significant revenue and margin growth, generating record free cash flow, and is well-positioned for 2025 with a "Buy" rating and a target share price of $100.08. Key risks include currency fluctuations, raw material costs, and competition, but strong daily demand for products and innovation in high-growth segments like Pet Nutrition support long-term growth. Read the full article on Seeking Alpha
Seeking Alpha • Mar 20

Colgate-Palmolive: A Defensive Stock With Growth Potential

Summary Colgate-Palmolive is one of the leaders in the global toothpaste market. On January 31, Colgate-Palmolive released financial results that left me with mixed reactions. Demand for its products in Latin America is growing rapidly, but the strengthening of the US dollar has not allowed Colgate-Palmolive to fully reflect this in its EPS. In this article, you, Seeking Alpha readers, will learn why, according to my "ALLKA 4D Rating" model, Colgate-Palmolive is a stock with an attractive risk/reward ratio. Read the full article on Seeking Alpha
Seeking Alpha • Mar 14

Is Colgate-Palmolive Quietly Building The Next Pet Food Empire?

Summary Colgate-Palmolive's premiumization strategy and pet nutrition expansion offer significant growth potential, with a price target of $115 per share, suggesting a 26% upside. Despite high valuation metrics, CL's superior profitability, high margins, and exceptional cash flow justify its premium valuation and long-term investment appeal. The company's strong pricing power, particularly in premium oral care and pet food, positions it well against inflation and competitive pressures. Risks include potential valuation compression and competition in pet nutrition, but CL's consistent cash flow and brand strength mitigate these concerns. Read the full article on Seeking Alpha
Seeking Alpha • Feb 25

Colgate-Palmolive: Don't Get Your Hopes Up (Yet)

Summary After a strong first half of 2024, Colgate-Palmolive's stock continues to be an underperformer in the consumer staples sector. The stock is trading at a discount to the level implied by current margins, but there is a good reason for that. Margins are likely to come under pressure in 2025 and from a dividend point of view, CL also appears unattractive at the moment. Read the full article on Seeking Alpha
Seeking Alpha • Jan 31

Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment

Summary Toothpaste and manual toothbrushes market leader Colgate-Palmolive Company released its fourth quarter and full-year 2024 results today. Judging by the share price reaction, and considering CL stock is down more than 20% from its all-time high, this clearly looks like a “buy the dip” moment. However, I'll explain why I don't think it's a good idea to buy CL shares, either for dividend or total return investors, and despite the company's undoubtedly solid 2024 performance. Read the full article on Seeking Alpha
Seeking Alpha • Dec 17

Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again

Summary Colgate-Palmolive's (CL) revenue growth has been minimal over the past decade, with a CAGR of only 1.53%, not even keeping pace with inflation. Despite a 61-year streak of increasing dividends, CL's EPS growth has been stagnant, leading to a higher payout ratio. Increased advertising expenditures, particularly in digital, have shown higher ROI than traditional channels. CL's future growth may hinge on digital advertising and expanding into Personal and Home Care markets, but the current valuation is too high for a buy rating. Read the full article on Seeking Alpha
Seeking Alpha • Dec 11

Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts

Summary As expected, Colgate-Palmolive's stock has retreated from its recent highs over the past few months. Upside potential for 2025 remains limited as gross margin tailwinds are fading. Nonetheless, there are some key areas that investors should keep a close eye on over the course of next year. Read the full article on Seeking Alpha
Seeking Alpha • Oct 25

Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now

Summary Colgate-Palmolive Company's Q3 earnings showed mixed results, with revenue and EPS beating estimates but North America and Latin America sales declining, leading to a 3% stock drop. The company's improved gross margins and increased advertising spend are positive signs, but the market remains concerned about regional sales declines. The Pet Nutrition segment shows strong growth potential, driven by the pet humanization trend, and could be a key revenue catalyst. Given macroeconomic uncertainties and regional performance, I rate Colgate-Palmolive stock as a hold, awaiting further developments in NA, LatAm, and Pet Nutrition segments. Read the full article on Seeking Alpha
Seeking Alpha • Oct 17

Colgate-Palmolive: Very Close To A Buy Following Recent Pullback

Summary Colgate-Palmolive is a high-quality business with consistent revenue growth, stable gross profit margins, and a strong return on invested capital, making it a solid dividend stock. The company has an impressive 61-year streak of consecutive dividend growth, maintaining a healthy payout ratio of around 60%, ensuring future dividend increases. The recent pace of dividend growth is below par but in line with inflation and top-line business growth. The recent pullback has brought the share price down very close to fair value. With earnings around the corner now may be a good time to consider jumping aboard. Colgate has beaten earnings estimates during the last 5 consecutive quarters, and recent analyst revisions indicate FQ3 may follow suit. Read the full article on Seeking Alpha
Seeking Alpha • Sep 30

Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)

Summary Since I turned bullish on the stock, Colgate-Palmolive delivered a 36% total return in less than 10 months. For a consumer staples company the size of CL, returns will most likely moderate from here for two main reasons. As the impact of pricing initiatives fades away, investors should keep a close eye on volumes over the coming year. Read the full article on Seeking Alpha
Seeking Alpha • Aug 19

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Summary Colgate-Palmolive operates globally with a strong presence in over 200 countries, deriving two-thirds of revenue from non-US markets. The Company is a member of the Dividend Kings group, offering reliable dividend income, which grew consecutively for 60 years. Strong organic growth in primary segments (partially offset by FX fluctuations), with profitable operations and solid margins ensuring shareholder rewards. Upon stock price increases during the last couple of quarters, CL's multiple reached its fair level. Therefore, I remain a happy holder, but I've stopped adding. Read the full article on Seeking Alpha

Kazanç ve Gelir Büyüme Tahminleri

NYSE:CL - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202822,8913,4973,7034,30411
12/31/202722,1393,1233,4073,94017
12/31/202621,4313,0412,7843,43217
3/31/202620,7952,0883,7674,345N/A
12/31/202520,3822,1323,6344,198N/A
9/30/202520,0972,9083,4434,014N/A
6/30/202519,9982,9083,3703,920N/A
3/31/202519,9472,8963,4674,026N/A
12/31/202420,1012,8893,5464,107N/A
9/30/202420,1062,8683,4003,974N/A
6/30/202419,9892,8403,3583,959N/A
3/31/202419,7522,6113,0233,691N/A
12/31/202319,4572,3003,0403,745N/A
9/30/202319,1361,5872,5533,282N/A
6/30/202318,6761,4972,3563,099N/A
3/31/202318,3381,5982,1682,905N/A
12/31/202217,9671,7851,8602,556N/A
9/30/202217,7411,9282,3212,989N/A
6/30/202217,7001,9442,3843,014N/A
3/31/202217,4762,0442,5313,113N/A
12/31/202117,4212,1662,7583,325N/A
9/30/202117,3422,6652,6473,182N/A
6/30/202117,0812,7292,6623,150N/A
3/31/202116,7182,6613,1143,549N/A
12/31/202016,4712,6953,3093,719N/A
9/30/202016,1622,6913,3683,726N/A
6/30/202015,9372,5713,3303,678N/A
3/31/202015,9062,5222,9503,296N/A
12/31/201915,6932,367N/A3,133N/A
9/30/201915,4892,330N/A3,025N/A
6/30/201915,4062,275N/A3,008N/A
3/31/201915,4262,326N/A3,045N/A
12/31/201815,5442,400N/A3,056N/A
9/30/201815,6252,117N/A2,953N/A
6/30/201815,7542,201N/A3,046N/A
3/31/201815,6942,088N/A2,979N/A
12/31/201715,4542,024N/A3,054N/A
9/30/201715,2832,307N/A3,119N/A
6/30/201715,1762,402N/A3,126N/A
3/31/201715,1952,478N/A3,218N/A
12/31/201615,1952,441N/A3,141N/A
9/30/201615,3732,461N/A3,158N/A
6/30/201615,5052,485N/A3,046N/A
3/31/201615,7262,459N/A2,836N/A
12/31/201516,0342,468N/A2,949N/A
9/30/201516,3562,470N/A3,014N/A
6/30/201516,7362,286N/A3,132N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CL 'nin tahmini kazanç büyümesi (yıllık 12.1% ) tasarruf oranının ( 3.5% ) üzerindedir.

Kazançlar ve Piyasa: CL şirketinin kazançlarının (yıllık 12.1% ) US pazarından (yıllık 16.8% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: CL şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: CL şirketinin gelirinin (yıllık 3.2% ) US pazarından (yıllık 11.7% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CL şirketinin gelirinin (yıllık 3.2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CL 'nin Özsermaye Getirisi'nin 3 yıl içinde çok yüksek olması tahmin ediliyor ( 255.3 %).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/18 04:04
Gün Sonu Hisse Fiyatı2026/05/15 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Colgate-Palmolive Company 43 Bu analistlerden 17, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Christopher GrajaArgus Research Company
Lauren LiebermanBarclays
Lauren LiebermanBarclays